CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: azacycloalkane
Accession: CHEBI:37949
browse the term
Synonyms: related_synonym: azacycloalkanes
G
Ace
angiotensin I converting enzyme
decreases activity
ISO
nicotianamine results in decreased activity of ACE protein
CTD
PMID:26106051
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
decreases activity
ISO
nicotianamine results in decreased activity of ACE2 protein
CTD
PMID:26106051
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Cat
catalase
decreases expression
ISO
1,4,7-triazacyclononane results in decreased expression of CAT protein
CTD
PMID:32869927
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
1,4,7-triazacyclononane results in increased expression of GPX1 protein
CTD
PMID:32869927
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
ISO
1,4,7-triazacyclononane results in increased expression of NFE2L2 protein
CTD
PMID:32869927
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
azetidine inhibits the reaction [Adenosine Triphosphate results in increased secretion of CCL3 protein]
CTD
PMID:26522449
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ctsb
cathepsin B
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of CTSB protein]
CTD
PMID:26522449
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
azetidine inhibits the reaction [Adenosine Triphosphate results in increased secretion of CXCL2 protein]
CTD
PMID:26522449
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Il6
interleukin 6
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of IL6 protein]
CTD
PMID:26522449
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased phosphorylation of MAPK1 protein]
CTD
PMID:26522449
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased phosphorylation of MAPK3 protein]
CTD
PMID:26522449
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of MMP9 protein]
CTD
PMID:26522449
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate affects the localization of NFATC1 protein]
CTD
PMID:26522449
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of NOS2 protein]
CTD
PMID:26522449
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
P2rx7
purinergic receptor P2X 7
multiple interactions
ISO
azetidine analog inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased expression of P2RX7 protein]; azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of P2RX7 protein]
CTD
PMID:26522449
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
ISO
azetidine analog inhibits the reaction [Adenosine Triphosphate results in decreased secretion of TIMP1 protein]
CTD
PMID:26522449
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
multiple interactions
ISO
azetidine analog inhibits the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased secretion of TNF protein]; azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased secretion of TNF protein]
CTD
PMID:26522449
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
affects localization
ISO
azetidine affects the localization of TRP53 protein
CTD
PMID:18813348
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Cryab
crystallin, alpha B
increases expression
ISO
Azetidinecarboxylic Acid results in increased expression of CRYAB protein
CTD
PMID:8113214
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Azetidinecarboxylic Acid results in increased expression of HSPA1A mRNA
CTD
PMID:12085988
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
Azetidinecarboxylic Acid results in increased expression of HSPA1B mRNA
CTD
PMID:12085988
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
Azetidinecarboxylic Acid results in increased expression of HSPB1 protein
CTD
PMID:8113214
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Guanethidine results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Acp5
acid phosphatase 5, tartrate resistant
affects expression increases expression
EXP
Guanethidine affects the expression of ACP5 protein Guanethidine results in increased expression of ACP5 mRNA
CTD
PMID:14527964
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Ctsk
cathepsin K
increases expression affects expression
EXP
Guanethidine results in increased expression of CTSK mRNA Guanethidine affects the expression of CTSK protein
CTD
PMID:14527964
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]
CTD
PMID:16510159
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Mmp13
matrix metallopeptidase 13
increases expression
EXP
Guanethidine results in increased expression of MMP13 mRNA
CTD
PMID:14527964
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Npy
neuropeptide Y
decreases expression decreases secretion
EXP ISO
Guanethidine results in decreased expression of NPY protein Guanethidine results in decreased secretion of NPY protein
CTD
PMID:9460767 PMID:14527964 PMID:15003356
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Serpine1
serpin family E member 1
multiple interactions
ISO
Guanethidine inhibits the reaction [Kainic Acid results in increased expression of SERPINE1 mRNA]
CTD
PMID:15850565
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Th
tyrosine hydroxylase
decreases expression
EXP
Guanethidine results in decreased expression of TH protein
CTD
PMID:9460767
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Vip
vasoactive intestinal peptide
decreases expression
EXP
Guanethidine results in decreased expression of VIP protein
CTD
PMID:14527964
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
CYP2E1 protein affects the metabolism of and results in increased activity of N-nitrosopiperidine
CTD
PMID:11774366
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
N-nitrosopiperidine results in increased cleavage of PARP1 protein
CTD
PMID:17929238
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Ace
angiotensin I converting enzyme
decreases activity
ISO
nicotianamine results in decreased activity of ACE protein
CTD
PMID:26106051
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
decreases activity
ISO
nicotianamine results in decreased activity of ACE2 protein
CTD
PMID:26106051
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Adora2a
adenosine A2a receptor
decreases expression
ISO
Phencyclidine results in decreased expression of ADORA2A mRNA
CTD
PMID:17266109
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Ajuba
ajuba LIM protein
increases expression
ISO
Phencyclidine results in increased expression of AJUBA mRNA
CTD
PMID:12105081
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
ISO
Phencyclidine results in increased expression of ALDH1A1 mRNA
CTD
PMID:17266109
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Apod
apolipoprotein D
increases expression
ISO
Phencyclidine results in increased expression of APOD mRNA
CTD
PMID:17266109
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
Apol2
apolipoprotein L, 2
increases expression
ISO
Phencyclidine results in increased expression of APOL2 mRNA
CTD
PMID:17205118
NCBI chr 7:109,331,367...109,338,632
Ensembl chr 7:109,331,392...109,338,558
G
Arhgef9
Cdc42 guanine nucleotide exchange factor 9
decreases expression
ISO
Phencyclidine results in decreased expression of ARHGEF9 mRNA
CTD
PMID:17266109
NCBI chr X:59,919,560...60,077,538
Ensembl chr X:59,920,870...60,077,513
G
Calm1
calmodulin 1
decreases expression
ISO
Phencyclidine results in decreased expression of CALM1 mRNA
CTD
PMID:17205118
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Calm2
calmodulin 2
decreases expression
ISO
Phencyclidine results in decreased expression of CALM2 mRNA
CTD
PMID:17205118
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
increases expression decreases expression
ISO
Phencyclidine results in increased expression of CAMK2A mRNA Phencyclidine results in decreased expression of CAMK2A mRNA
CTD
PMID:17266109
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
decreases expression
ISO
Phencyclidine results in decreased expression of CAMK2B mRNA
CTD
PMID:17205118
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Casp1
caspase 1
increases expression
ISO
Phencyclidine results in increased expression of CASP1 mRNA
CTD
PMID:12105081
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
multiple interactions increases activity
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]; Cadmium Chloride inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]; Nifedipine inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]; omega-agatoxin-Aa4b inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]; staurosporine aglycone inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]
CTD
PMID:24995437
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cckbr
cholecystokinin B receptor
increases expression
ISO
Phencyclidine results in increased expression of CCKBR mRNA
CTD
PMID:17266109
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
Phencyclidine results in increased expression of CDK5R1 mRNA
CTD
PMID:17266109
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
decreases expression increases expression
ISO
Phencyclidine results in decreased expression of CNP mRNA Phencyclidine results in increased expression of CNP mRNA
CTD
PMID:17266109
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Cnr1
cannabinoid receptor 1
multiple interactions
ISO
[Phencyclidine co-treated with Dronabinol] results in decreased expression of CNR1 protein
CTD
PMID:28648819
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cplx2
complexin 2
decreases expression
ISO
Phencyclidine results in decreased expression of CPLX2 mRNA
CTD
PMID:17266109
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
G
Cyba
cytochrome b-245 alpha chain
multiple interactions increases activity
ISO
acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of CYBA protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of CYBA protein]]; ginsenoside Re inhibits the reaction [Phencyclidine results in increased activity of CYBA protein]; GPX1 protein affects the reaction [Phencyclidine results in increased activity of CYBA protein]
CTD
PMID:29037473
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases activity affects oxidation affects metabolic processing
ISO
Phencyclidine analog results in decreased activity of CYP2B6 protein; Phencyclidine results in decreased activity of CYP2B6 protein CYP2B6 protein affects the oxidation of Phencyclidine CYP2B6 protein affects the metabolism of Phencyclidine analog
CTD
PMID:16782764
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects oxidation decreases activity
ISO
CYP2C19 protein affects the oxidation of Phencyclidine Phencyclidine results in decreased activity of CYP2C19 protein
CTD
PMID:16782764
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
affects metabolic processing
ISO
CYP2C8 protein affects the metabolism of Phencyclidine
CTD
PMID:16782764
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing
ISO
CYP2D6 protein affects the metabolism of Phencyclidine
CTD
PMID:16782764
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
affects metabolic processing
ISO
CYP3A4 protein affects the metabolism of Phencyclidine
CTD
PMID:16782764
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
affects metabolic processing
ISO
CYP3A5 protein affects the metabolism of Phencyclidine
CTD
PMID:16782764
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Ddo
D-aspartate oxidase
multiple interactions affects response to substance
ISO
[DDO protein affects the susceptibility to Phencyclidine] which affects the expression of DLG4 mRNA; [DDO protein affects the susceptibility to Phencyclidine] which affects the expression of HOMER1 mRNA; DDO protein affects the reaction [Phencyclidine results in decreased expression of HOMER1 mRNA]; DDO protein affects the reaction [Phencyclidine results in increased expression of DLG4 mRNA]
CTD
PMID:25979765
NCBI chr20:44,090,823...44,109,962
Ensembl chr20:44,090,914...44,133,095
G
Dlg4
discs large MAGUK scaffold protein 4
multiple interactions increases expression
ISO
[DDO protein affects the susceptibility to Phencyclidine] which affects the expression of DLG4 mRNA; DDO protein affects the reaction [Phencyclidine results in increased expression of DLG4 mRNA]
CTD
PMID:25979765
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
G
Dnajc1
DnaJ heat shock protein family (Hsp40) member C1
decreases expression
ISO
Phencyclidine results in decreased expression of DNAJC1 mRNA
CTD
PMID:12105081
NCBI chr17:80,955,209...81,112,025
Ensembl chr17:80,955,237...81,111,988
G
Drd1
dopamine receptor D1
decreases expression multiple interactions
ISO
Phencyclidine results in decreased expression of DRD1 mRNA; Phencyclidine results in decreased expression of DRD1 protein NTSR1 gene affects the reaction [Phencyclidine results in decreased expression of DRD1 protein]
CTD
PMID:17266109 PMID:20659557
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
decreases expression affects binding
ISO EXP
Phencyclidine results in decreased expression of DRD2 mRNA; Phencyclidine results in decreased expression of DRD2 protein Phencyclidine binds to Drd2 protein
CTD RGD
PMID:17266109 PMID:20659557 PMID:15852061
RGD:1581406
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Egf
epidermal growth factor
increases expression
ISO
Phencyclidine results in increased expression of EGF mRNA
CTD
PMID:12105081
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
ISO
Phencyclidine results in increased expression of FDFT1 mRNA
CTD
PMID:17205118
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
[Dextroamphetamine co-treated with Phencyclidine] promotes the reaction [FOS protein binds to FOS promoter]; [Dextroamphetamine co-treated with Phencyclidine] promotes the reaction [SRF protein binds to FOS promoter]; [Dextroamphetamine co-treated with Phencyclidine] results in increased expression of FOS protein; [Phencyclidine co-treated with Dextroamphetamine] results in increased expression of FOS protein; Phencyclidine promotes the reaction [FOS protein binds to FOS promoter]; Phencyclidine promotes the reaction [SRF protein binds to FOS promoter] Phencyclidine results in increased expression of FOS protein
CTD
PMID:12510024 PMID:16678866
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
[Phencyclidine co-treated with Dextroamphetamine] results in increased expression of FOSB protein Phencyclidine results in increased expression of FOSB protein
CTD
PMID:16678866
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Foxp2
forkhead box P2
increases expression
ISO
Phencyclidine results in increased expression of FOXP2 mRNA
CTD
PMID:17266109
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
decreases expression
ISO
Phencyclidine results in decreased expression of GABBR1 mRNA
CTD
PMID:17266109
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
increases expression
ISO
Phencyclidine results in increased expression of GABRA1 mRNA
CTD
PMID:17266109
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gad2
glutamate decarboxylase 2
increases expression
ISO
Phencyclidine results in increased expression of GAD2 mRNA
CTD
PMID:17266109
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Gap43
growth associated protein 43
increases expression
EXP
Phencyclidine results in increased expression of GAP43 mRNA
CTD
PMID:11377751
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gcc1
GRIP and coiled-coil domain containing 1
increases expression
ISO
Phencyclidine results in increased expression of GCC1 mRNA
CTD
PMID:17205118
NCBI chr 4:57,030,817...57,042,682
Ensembl chr 4:57,032,314...57,042,663
G
Gfap
glial fibrillary acidic protein
increases expression
ISO
Phencyclidine results in increased expression of GFAP mRNA
CTD
PMID:17266109
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gnas
GNAS complex locus
increases expression
ISO
Phencyclidine results in increased expression of GNAS mRNA
CTD
PMID:12105081
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine affects the localization of NCF1 protein]]; acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in decreased activity of SOD2 protein]]; acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of CYBA protein]]; acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of SOD1 protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine affects the localization of NCF1 protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in decreased activity of SOD2 protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of CYBA protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of SOD1 protein]]; GPX1 protein affects the reaction [Phencyclidine affects the localization of NCF1 protein]; GPX1 protein affects the reaction [Phencyclidine results in decreased activity of SOD2 protein]; GPX1 protein affects the reaction [Phencyclidine results in increased activity of CYBA protein]; GPX1 protein affects the reaction [Phencyclidine results in increased activity of SOD1 protein]
CTD
PMID:29037473
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gria4
glutamate ionotropic receptor AMPA type subunit 4
increases expression
ISO
Phencyclidine results in increased expression of GRIA4 mRNA
CTD
PMID:17266109
NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression multiple interactions
ISO
Phencyclidine results in decreased expression of GRIN1 mRNA; Phencyclidine results in decreased expression of GRIN1 protein [Phencyclidine co-treated with Dronabinol] results in decreased expression of GRIN1 protein
CTD
PMID:17266109 PMID:28648819
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
decreases expression
ISO
Phencyclidine results in decreased expression of GRIN2A mRNA; Phencyclidine results in decreased expression of GRIN2A protein
CTD
PMID:20659557
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
EXP
Phencyclidine results in increased expression of HMOX1 mRNA; Phencyclidine results in increased expression of HMOX1 protein 1,3-dimethylthiourea inhibits the reaction [Phencyclidine results in increased expression of HMOX1 protein]
CTD
PMID:9875361
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Homer1
homer scaffold protein 1
multiple interactions decreases expression
ISO
[DDO protein affects the susceptibility to Phencyclidine] which affects the expression of HOMER1 mRNA; DDO protein affects the reaction [Phencyclidine results in decreased expression of HOMER1 mRNA]
CTD
PMID:25979765
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Hoxb9
homeo box B9
decreases expression
ISO
Phencyclidine results in decreased expression of HOXB9 mRNA
CTD
PMID:12105081
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions decreases activity
EXP
[Phencyclidine co-treated with Haloperidol] affects the activity of HTR2A protein; Clozapine promotes the reaction [Phencyclidine results in decreased activity of HTR2A protein]
CTD
PMID:15380371
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[Phencyclidine co-treated with Dextroamphetamine] results in increased expression of JUND protein
CTD
PMID:16678866
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kcnh1
potassium voltage-gated channel subfamily H member 1
decreases expression
ISO
Phencyclidine results in decreased expression of KCNH1 mRNA
CTD
PMID:12105081
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
G
Kcnip3
potassium voltage-gated channel interacting protein 3
increases expression
ISO
Phencyclidine results in increased expression of KCNIP3 mRNA
CTD
PMID:17266109
NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556
G
Kcnj4
potassium inwardly-rectifying channel, subfamily J, member 4
increases expression
ISO
Phencyclidine results in increased expression of KCNJ4 mRNA
CTD
PMID:17266109
NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151
G
Kitlg
KIT ligand
increases expression
ISO
Phencyclidine results in increased expression of KITL mRNA
CTD
PMID:12105081
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Lep
leptin
increases expression
ISO
Phencyclidine results in increased expression of LEP mRNA
CTD
PMID:12105081
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lpl
lipoprotein lipase
increases expression
ISO
Phencyclidine results in increased expression of LPL mRNA
CTD
PMID:17266109
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
Phencyclidine results in decreased expression of MAL mRNA
CTD
PMID:17266109
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Maob
monoamine oxidase B
increases expression
ISO
Phencyclidine results in increased expression of MAOB mRNA
CTD
PMID:17266109
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Mapk8ip1
mitogen-activated protein kinase 8 interacting protein 1
increases expression
ISO
Phencyclidine results in increased expression of MAPK8IP1 mRNA
CTD
PMID:17266109
NCBI chr 3:78,355,051...78,372,946
Ensembl chr 3:78,355,048...78,372,884
G
Mbp
myelin basic protein
increases expression
ISO
Phencyclidine results in increased expression of MBP mRNA
CTD
PMID:17266109
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mobp
myelin-associated oligodendrocyte basic protein
increases expression
ISO
Phencyclidine results in increased expression of MOBP mRNA
CTD
PMID:17266109
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
G
Ncf1
neutrophil cytosolic factor 1
affects localization multiple interactions
ISO
Phencyclidine affects the localization of NCF1 protein acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine affects the localization of NCF1 protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine affects the localization of NCF1 protein]]; ginsenoside Re inhibits the reaction [Phencyclidine affects the localization of NCF1 protein]; GPX1 protein affects the reaction [Phencyclidine affects the localization of NCF1 protein]
CTD
PMID:29037473
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Phencyclidine results in increased expression of NR4A2 mRNA
CTD
PMID:17266109
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Ntsr1
neurotensin receptor 1
multiple interactions
ISO
NTSR1 gene affects the reaction [Phencyclidine results in decreased expression of DRD1 protein]
CTD
PMID:20659557
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
G
P2ry1
purinergic receptor P2Y1
increases expression
ISO
Phencyclidine results in increased expression of P2RY1 mRNA
CTD
PMID:12105081
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
G
Pde10a
phosphodiesterase 10A
increases expression
ISO
Phencyclidine results in increased expression of PDE10A mRNA
CTD
PMID:17266109
NCBI chr 1:51,765,743...52,218,086
Ensembl chr 1:51,770,132...52,216,563
G
Plp1
proteolipid protein 1
increases expression
ISO
Phencyclidine results in increased expression of PLP1 mRNA
CTD
PMID:17266109
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Prkcd
protein kinase C, delta
increases expression
ISO
Phencyclidine results in increased expression of PRKCD mRNA
CTD
PMID:12105081
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkcg
protein kinase C, gamma
increases expression
EXP
Phencyclidine results in increased expression of PRKCG mRNA
CTD
PMID:11169168
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:65,832,855...65,859,384
G
Ptgds
prostaglandin D2 synthase
increases expression
ISO
Phencyclidine results in increased expression of PTGDS mRNA
CTD
PMID:17266109
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
G
Ptprcap
protein tyrosine phosphatase, receptor type, C-associated protein
increases expression
ISO
Phencyclidine results in increased expression of PTPRCAP mRNA
CTD
PMID:12105081
NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:201,449,113...201,451,288
G
Pvalb
parvalbumin
multiple interactions decreases expression
EXP
Clozapine inhibits the reaction [Phencyclidine results in decreased expression of PVALB mRNA]; Haloperidol inhibits the reaction [Phencyclidine results in decreased expression of PVALB mRNA]
CTD
PMID:12589379
NCBI chr 7:109,772,939...109,787,954
Ensembl chr 7:109,772,593...109,784,561
G
Reln
reelin
decreases expression
ISO
Phencyclidine results in decreased expression of RELN mRNA
CTD
PMID:17266109
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rgs4
regulator of G-protein signaling 4
increases expression
ISO
Phencyclidine results in increased expression of RGS4 mRNA
CTD
PMID:17266109
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rtn4
reticulon 4
increases expression
ISO
Phencyclidine results in increased expression of RTN4 mRNA
CTD
PMID:17266109
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
Phencyclidine results in increased expression of SCARB1 mRNA
CTD
PMID:17205118
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Selplg
selectin P ligand
increases expression
ISO
Phencyclidine results in increased expression of SELPLG mRNA
CTD
PMID:12105081
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
G
Sema3b
semaphorin 3B
decreases expression
ISO
Phencyclidine results in decreased expression of SEMA3B mRNA
CTD
PMID:17205118
NCBI chr 8:108,271,663...108,280,326
Ensembl chr 8:108,271,666...108,282,919
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
Phencyclidine results in increased expression of SGK1 mRNA
CTD
PMID:17266109
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Slc17a6
solute carrier family 17 member 6
increases expression
ISO
Phencyclidine results in increased expression of SLC17A6 mRNA
CTD
PMID:17266109
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Smad5
SMAD family member 5
decreases expression
ISO
Phencyclidine results in decreased expression of SMAD5 mRNA
CTD
PMID:12105081
NCBI chr17:7,862,332...7,891,678
Ensembl chr17:7,864,720...7,891,634
G
Sod1
superoxide dismutase 1
increases activity multiple interactions
ISO
Phencyclidine results in increased activity of SOD1 protein acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of SOD1 protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in increased activity of SOD1 protein]]; GPX1 protein affects the reaction [Phencyclidine results in increased activity of SOD1 protein]
CTD
PMID:29037473
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases activity multiple interactions
ISO
Phencyclidine results in decreased activity of SOD2 protein acetovanillone inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in decreased activity of SOD2 protein]]; ginsenoside Re inhibits the reaction [GPX1 protein affects the reaction [Phencyclidine results in decreased activity of SOD2 protein]]; GPX1 protein affects the reaction [Phencyclidine results in decreased activity of SOD2 protein]
CTD
PMID:29037473
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases expression
EXP
Phencyclidine results in increased expression of SRC mRNA
CTD
PMID:11249956
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srf
serum response factor
multiple interactions
EXP
[Dextroamphetamine co-treated with Phencyclidine] promotes the reaction [SRF protein binds to FOS promoter]; Phencyclidine promotes the reaction [SRF protein binds to FOS promoter]
CTD
PMID:12510024
NCBI chr 9:14,426,453...14,435,734
Ensembl chr 9:14,426,472...14,435,733
G
Syn2
synapsin II
decreases expression
ISO
Phencyclidine results in decreased expression of SYN2 mRNA
CTD
PMID:17266109
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
G
Syt2
synaptotagmin 2
increases expression
ISO
Phencyclidine results in increased expression of SYT2 mRNA
CTD
PMID:17266109
NCBI chr13:46,088,046...46,197,976
Ensembl chr13:46,185,282...46,193,859
G
Tac1
tachykinin, precursor 1
decreases expression
ISO
Phencyclidine results in decreased expression of TAC1 mRNA
CTD
PMID:17266109
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tead4
TEA domain transcription factor 4
decreases expression
ISO
Phencyclidine results in decreased expression of TEAD4 mRNA
CTD
PMID:12105081
NCBI chr 4:161,474,122...161,572,837
Ensembl chr 4:161,497,851...161,572,323
G
Th
tyrosine hydroxylase
multiple interactions increases expression
ISO
Phencyclidine inhibits the reaction [Methamphetamine results in decreased activity of TH protein] Phencyclidine results in increased expression of TH mRNA
CTD
PMID:1381816 PMID:12105081
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
multiple interactions affects expression
EXP
Haloperidol affects the reaction [Phencyclidine affects the expression of TNF mRNA]
CTD
PMID:16478754
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ttr
transthyretin
decreases expression
ISO
Phencyclidine results in decreased expression of TTR mRNA
CTD
PMID:17266109
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
decreases expression
ISO
Phencyclidine results in decreased expression of YWHAB mRNA
CTD
PMID:17266109
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Zrsr2-ps1
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2, pseudogene 1
decreases expression
ISO
Phencyclidine results in decreased expression of ZRSR2-PS1 mRNA
CTD
PMID:12105081
NCBI chr14:96,972,651...96,978,364
Ensembl chr14:96,972,580...96,978,891
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Piperazine analog results in increased expression of BAX protein
CTD
PMID:28874085
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Piperazine analog results in decreased expression of BCL2 protein
CTD
PMID:28874085
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases cleavage
ISO
Piperazine analog results in increased cleavage of CASP3 protein
CTD
PMID:28874085
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
increases activity
ISO
Piperazine analog results in increased activity of CAT protein
CTD
PMID:28874085
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Il2
interleukin 2
decreases expression
ISO
piperazine analog results in decreased expression of IL2 mRNA
CTD
PMID:11859000
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Sod1
superoxide dismutase 1
increases activity
ISO
Piperazine analog results in increased activity of SOD1 protein
CTD
PMID:28874085
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Th
tyrosine hydroxylase
decreases expression
ISO
Piperazine analog results in decreased expression of TH protein
CTD
PMID:28874085
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Ache
acetylcholinesterase
multiple interactions decreases activity
ISO
piperidine analog inhibits the reaction [ACHE protein promotes the reaction [APP protein binds to APP protein]] piperidine analog results in decreased activity of ACHE protein
CTD
PMID:17681794
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
App
amyloid beta precursor protein
multiple interactions
ISO
piperidine analog inhibits the reaction [ACHE protein promotes the reaction [APP protein binds to APP protein]]; piperidine analog inhibits the reaction [APP protein binds to APP protein]
CTD
PMID:17681794
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bche
butyrylcholinesterase
decreases activity
ISO
piperidine analog results in decreased activity of BCHE protein
CTD
PMID:17681794
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
piperidine inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]
CTD
PMID:17706638
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
ISO
piperidine inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]
CTD
PMID:17706638
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ifng
interferon gamma
multiple interactions
ISO
piperidine inhibits the reaction [Cadmium Chloride results in decreased secretion of IFNG protein]
CTD
PMID:17706638
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il2
interleukin 2
decreases expression multiple interactions
ISO
piperidine analog results in decreased expression of IL2 mRNA piperidine inhibits the reaction [Cadmium Chloride results in decreased secretion of IL2 protein]
CTD
PMID:11859000 PMID:17706638
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Srd5a1
steroid 5 alpha-reductase 1
decreases activity
ISO EXP
piperidine analog results in decreased activity of SRD5A1 protein
CTD
PMID:10896124
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srd5a2
steroid 5 alpha-reductase 2
decreases activity
ISO EXP
piperidine analog results in decreased activity of SRD5A2 protein
CTD
PMID:10896124
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Pizotyline results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP ISO
plerixafor inhibits the reaction [naringin results in increased phosphorylation of AKT1 protein] plerixafor inhibits the reaction [CXCL12 protein results in increased phosphorylation of AKT1 protein]
CTD
PMID:18660423 PMID:29510123
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Cdh1
cadherin 1
multiple interactions increases expression
ISO
plerixafor inhibits the reaction [bisphenol A results in decreased expression of CDH1 protein]; plerixafor inhibits the reaction [Estradiol results in decreased expression of CDH1 protein]; plerixafor inhibits the reaction [Triclosan results in decreased expression of CDH1 protein] plerixafor increases expression of CDH1 protein in lymph node and prostate epithelium
CTD RGD
PMID:28844962 PMID:30537000
RGD:152025215
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
decreases expression
ISO
plerixafor decreases expression of CDH2 protein in lymph node and prostate epithelium
RGD
PMID:30537000
RGD:152025215
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions decreases expression
ISO
plerixafor inhibits the reaction [CXCL12 protein affects the localization of CXCR4 protein]; plerixafor inhibits the reaction [CXCL12 protein results in increased phosphorylation of AKT1 protein]; plerixafor inhibits the reaction [CXCL12 protein results in increased phosphorylation of NOS3 protein] plerixafor results in decreased expression of CXCL12 mRNA
CTD
PMID:12220670 PMID:18660423 PMID:24157575
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcr4
C-X-C motif chemokine receptor 4
decreases activity decreases phosphorylation decreases expression multiple interactions
ISO EXP
plerixafor results in decreased activity of CXCR4 protein plerixafor decreases phosphorylation of CXCR4 protein in lymph node and prostate epithelium plerixafor decreases expression of CXCR4 mRNA and protein in lymph node and prostate epithelium Plerixafor decreases expression of CXCR4 protein in liver plerixafor binds to and results in decreased activity of CXCR4 protein; plerixafor inhibits the reaction [bisphenol A results in increased expression of CXCR4 protein]; plerixafor inhibits the reaction [CXCL12 protein affects the localization of CXCR4 protein]; plerixafor inhibits the reaction [Estradiol results in increased expression of CXCR4 protein]; plerixafor inhibits the reaction [Triclosan results in increased expression of CXCR4 protein] plerixafor results in decreased expression of CXCR4 protein
CTD RGD
PMID:12220670 PMID:17121897 PMID:28844962 PMID:30537000 PMID:30537000 PMID:24912495 More...
RGD:152025215 , RGD:152025215 , RGD:151893463
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Nos3
nitric oxide synthase 3
multiple interactions
ISO
plerixafor inhibits the reaction [CXCL12 protein results in increased phosphorylation of NOS3 protein]
CTD
PMID:18660423
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Snai2
snail family transcriptional repressor 2
multiple interactions
ISO
plerixafor inhibits the reaction [bisphenol A results in increased expression of SNAI2 protein]; plerixafor inhibits the reaction [Estradiol results in increased expression of SNAI2 protein]; plerixafor inhibits the reaction [Triclosan results in increased expression of SNAI2 protein]
CTD
PMID:28844962
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Particulate Matter results in decreased susceptibility to [VEGFA protein modified form co-treated with plerixafor] plerixafor inhibits the reaction [cobaltous chloride results in increased secretion of VEGFA protein]
CTD
PMID:22418586 PMID:25815440
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
decreases expression
ISO
plerixafor decreases expression on VIM protein in lymph node and prostate epithelium
RGD
PMID:30537000
RGD:152025215
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Hrh3
histamine receptor H3
multiple interactions
EXP ISO
pyrrolidine binds to and results in decreased activity of HRH3 protein
CTD
PMID:17169555
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
G
Pon1
paraoxonase 1
multiple interactions
ISO
[pyrrolidine analog binds to Palladium binds to Diclofenac] which results in decreased activity of PON1 protein; [pyrrolidine analog binds to Palladium binds to Mefenamic Acid] which results in decreased activity of PON1 protein; [pyrrolidine analog binds to Platinum binds to Diclofenac] which results in decreased activity of PON1 protein; [pyrrolidine analog binds to Platinum binds to Mefenamic Acid] which results in decreased activity of PON1 protein
CTD
PMID:29512227
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19834
chemical entity
19832
atom
19832
nonmetal atom
19770
nitrogen atom
18959
nitrogen molecular entity
18959
organonitrogen compound
18809
organonitrogen heterocyclic compound
18150
azacycloalkane
145
1,3,5,7-tetrazocane
0
1,4,7,10-tetraazacyclododecane +
0
1,4,7-triazonane
3
1,4,8,11-tetraazacyclotetradecane +
9
azepane
0
azetidine +
19
aziridine +
0
aziridinium
0
azocane +
9
dihydromotuporamine C
0
imidazolidine +
0
piperazine
7
piperidine +
105
plerixafor
9
pyrazolidine
0
pyrrolidine +
2
triazinane +
0
Path 2
CHEBI ontology
19834
subatomic particle
19832
composite particle
19832
hadron
19832
baryon
19832
nucleon
19832
atomic nucleus
19832
atom
19832
main group element atom
19782
p-block element atom
19782
carbon group element atom
19730
carbon atom
19727
organic molecular entity
19727
organic molecule
19680
organic cyclic compound
19492
organic heterocyclic compound
18854
organic heteromonocyclic compound
17802
azacycloalkane
145
1,3,5,7-tetrazocane
0
1,4,7,10-tetraazacyclododecane +
0
1,4,7-triazonane
3
1,4,8,11-tetraazacyclotetradecane +
9
azepane
0
azetidine +
19
aziridine +
0
aziridinium
0
azocane +
9
dihydromotuporamine C
0
imidazolidine +
0
piperazine
7
piperidine +
105
plerixafor
9
pyrazolidine
0
pyrrolidine +
2
triazinane +
0